LY8888AX

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY8888AX, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY8888AX in Participants Using a Connected Insulin Management Platform [NA]